Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locoregionally Advanced”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT04414566
What this trial is testing

Induction Chemotherapy Plus Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
West China Hospital 562
Testing effectiveness (Phase 2)UnknownNCT02421640
What this trial is testing

Phase II Trial of TIL Following CCRT in Patients With Locoregionally Advanced NPC

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 116
Early research (Phase 1)Ended earlyNCT06110195
What this trial is testing

Study of Xevinapant With Radiation and Chemotherapy for Patients With Head and Neck Cancer

Who this might be right for
Head and Neck CancerHead and Neck NeoplasmsSquamous Cell Carcinoma of Head and Neck
University of Chicago 42
Testing effectiveness (Phase 2)Study completedNCT03107182
What this trial is testing

Chemotherapy and Locoregional Therapy Trial (Surgery or Radiation) for Patients With Head and Neck Cancer

Who this might be right for
HPV-Related Squamous Cell CarcinomaHNSCC
University of Chicago 72
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07346196
What this trial is testing

A Trial of Locoregionally Advanced Squamous Cell Carcinoma of The Head and Neck

Who this might be right for
Squamous Cell Carcinoma
University of Chicago 90
Large-scale testing (Phase 3)UnknownNCT01689558
What this trial is testing

Recombine Endostatin With Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation in Advanced Nasopharynx Cancer

Who this might be right for
1、Enough Cases2、Elekta Precise 1343 Digital Control Electron Linear AcceleratorCan Undertake Nasopharyngeal Carcinoma Specimens in the Materia，+1 more
Jin Feng 60
Testing effectiveness (Phase 2)Study completedNCT01173289
What this trial is testing

Study of External Beam Radiotherapy to Thyroid Carcinoma

Who this might be right for
Thyroid Cancer
National Cancer Center, Korea 62
Large-scale testing (Phase 3)Not Yet RecruitingNCT07540390
What this trial is testing

GAPP Induction and Concurrent Chemoradiotherapy for High-risk Locoregionally Advanced NPC.

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 442
Testing effectiveness (Phase 2)UnknownNCT03020329
What this trial is testing

Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaChildren
Sun Yat-sen University 37
Testing effectiveness (Phase 2)Study completedNCT04833257
What this trial is testing

Neoadjuvant Therapy of GP Chemotherapy Combined With Tislelizumab in Locoregionally Advanced NPC

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 63
Testing effectiveness (Phase 2)Study completedNCT04004871
What this trial is testing

Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaNasopharyngeal CancerNasopharynx Cancer
Guangxi Medical University 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT03047265
What this trial is testing

Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 164
Large-scale testing (Phase 3)Study completedNCT02012062
What this trial is testing

Concurrent Nimotuzumab Versus Cisplatin With Radiotherapy for Locoregionally Advanced NPC

Who this might be right for
Nasopharyngeal Carcinoma
Fudan University 160
Testing effectiveness (Phase 2)WithdrawnNCT03220009
What this trial is testing

Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma

Who this might be right for
Cervical CarcinomaEsophageal CarcinomaMucosal Melanoma+14 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00113347
What this trial is testing

Erlotinib and Docetaxel With Concomitant Boost Radiation Therapy (XRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)

Who this might be right for
Head and Neck Cancer
M.D. Anderson Cancer Center 10
Testing effectiveness (Phase 2)Study completedNCT04834206
What this trial is testing

Nedaplatin in Treatment for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Affiliated Cancer Hospital & Institute of Guangzhou Medical University 32
Early research (Phase 1)Study completedNCT02537223
What this trial is testing

Phase I Study of BYL719 in Combination With Cisplatin and Radiotherapy in Patients With Squamous Cell Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of Head and NeckLocoregionally Advanced
University Health Network, Toronto 9
Testing effectiveness (Phase 2)Study completedNCT03894891
What this trial is testing

Induction TPN Followed by Nivolumab With Radiation in Locoregionally Advanced Laryngeal and Hypopharyngeal Cancer

Who this might be right for
Head and Neck Cancer
Dana-Farber Cancer Institute 6
Large-scale testing (Phase 3)Looking for participantsNCT07796789
What this trial is testing

Prophylactic Nanocrystalline Megestrol Acetate Versus Placebo for Chemoradiotherapy-Related Anorexia in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University 204
Large-scale testing (Phase 3)UnknownNCT02958111
What this trial is testing

Single-agent Capecitabine as Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 406
Next Page